Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 32, 2018 - Issue 16
149
Views
4
CrossRef citations to date
0
Altmetric
Short Communication

The Proteins from Sika deer antler as potential modulators on cisplatin-induced cytotoxicity in human embryonic kidney 293 cells

, , , , &
Pages 1982-1986 | Received 06 May 2017, Accepted 26 Jun 2017, Published online: 31 Jul 2017

References

  • Chen X, Yan W, Yan W, Wang L, Wei L. 2009. Protective effects of the peptides from velvet antler on acute ischemic myocardial injury induced by isoproterenol in rats. Pharmacol Clin Chin Mat Med. 25:64–66.
  • Elnaga RN. 2014. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis. Toxicol Appl Pharmacol. 274:87–95.10.1016/j.taap.2013.10.031
  • Fatima S, Almohaimeed N, Alshaikh Y, Tyagi P, Banu N, Hasan S, Arjumand S. 2016. Combined treatment of epigallocatechin gallate and Coenzyme Q10 attenuates cisplatin-induced nephrotoxicity via suppression of oxidative/nitrosative stress, inflammation and cellular damage. Food Chem Toxicol. 94:213–220.10.1016/j.fct.2016.05.023
  • Gilbey A, Perezgonzalez JD. 2012. Health benefits of deer and elk velvet antler supplements: a systematic review of randomised controlled studies. New Zeal MedJ. 125:80–86.
  • Kawai Y, Nakao T, Kunimura N, Kohda Y, Gemba M. 2006. Relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J Pharm Sci. 100:65–72.10.1254/jphs.FP0050661
  • Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M. 2008. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemoth Pharm. 61:903–909.10.1007/s00280-008-0711-0
  • Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. 2010. Mechanisms of cisplatin nephrotoxicity. Toxins. 2:2490–2518.
  • Pabla N, Dong Z. 2008. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 73:994–1007.10.1038/sj.ki.5002786
  • Peres LA, Da CAJ. 2013. Acute nephrotoxicity of cisplatin: molecular mechanisms. J Brasileiro De Nefrol. 35:332–340.10.5935/0101-2800.20130052
  • Ramesh G, Reeves WB. 2005. P38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol. 289:166–174.10.1152/ajprenal.00401.2004
  • Suh SJ, Kim KS, Lee AR, Ha KT, Kim JK, Kim DS, Lee YC, Kim MS, Kwon DY, Kim CH. 2007. Prevention of collagen-induced arthritis in mice by Cervus korean Temminck var. mantchuricus Swinhoe. Environ Toxicol Pharmacol. 23:147–153.10.1016/j.etap.2006.08.001
  • Tiffany-Castiglioni E, Ehrich M, Dees L, Costa LG, Kodavanti PR, Lasley SM, Oortgiesen M, Durham HD. 1999. Bridging the gap between in vitro and in vivo models for neurotoxicology. Toxicological Sci J Soc Toxicol. 51:178–183.10.1093/toxsci/51.2.178
  • Xu X, Liu T, Zhang A, Huo X, Luo Q, Chen Z, Yu L, Li Q, Liu L, Lun Z, et al. 2012. Reactive oxygen species-triggered trophoblast apoptosis is initiated by endoplasmic reticulum stress via activation of Caspase-12, CHOP, and the JNK pathway in toxoplasma gondii infection in mice. Infec Immun. 80:2121–2132.10.1128/IAI.06295-11
  • Zhao L, Luo YC, Wang CT, Ji BP. 2011. Antioxidant activity of protein hydrolysates from aqueous extract of velvet antler (Cervus elaphus) as influenced by molecular weight and enzymes. Nat Prod Commun. 6:1683–1688.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.